Pharmacopeial requirements for elemental impurities: A novel approach to the trace determination of osmium by oxidative pressure vessel sample digestion and measurement using inductively coupled plasma mass spectrometry (ICP-MS) after complexation and stabilisation

Journal of Analytical Atomic Spectrometry

Volumn 28, Issue 7, 2013, Pages 1125-1129

  Venzago, Cornel ^a   Popp, Maximilian ^a   Kovac, Jessica ^a   Kunkel, Andrea ^a  

^a AQura GmbH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEXATION; EXPERIMENTS; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY; MASS SPECTROMETERS; NITRIC ACID; OSMIUM; PRESSURE VESSELS; THIOUREAS;

CONCENTRATED NITRIC ACID; ELEMENTAL CONCENTRATIONS; HIGH PRESSURE DIGESTION; INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRIES (ICPMS); PHARMACEUTICAL EXCIPIENT; PHARMACEUTICAL PRODUCTS; REGULATORY REQUIREMENTS; TRACE ELEMENTAL ANALYSIS;

STABILIZATION;

EID: 84883206271     PISSN: 02679477     EISSN: 13645544     Source Type: Journal    
DOI: 10.1039/c3ja50040c     Document Type: Article

References (19)

1. Guideline on the specification for residues of metal catalysts or metal reagents, Doc. Ref. EMEA/CHMP/SWP/4446/2000, European Medicines Agency, London, 2008
2. A. J. DeStefano, K. Zaidi, T. L. Cecil, G. I. Giancaspro, and, the USP Elemental Impurities Advisory Panel, General Chapter on Inorganic Impurities: Heavy Metals-Stimuli to the Revision Process, Pharmacopeial Forum, 2008, 34 (5), 1345 1348
3. A. J. DeStefano K. Zaidi T. L. Cecil G. I. Giancaspro USP Elemental Advisory board Elemental Impurities Comments and responses-Stimuli to the revision process Pharmacopeial Forum 2010 36 1 1 5
4. A. J. DeStefano K. Zaidi T. L. Cecil G. I. Giancaspro USP Elemental Advisory board Elemental Impurities-Information-Stimuli to the Revision Process Pharmacopeial Forum 2010 36 1 2 9
5. Final approved General Chapter 〈232〉 Elemental Impurities-Limits, USP35/NF30, 2nd supplement, revision bulletin, 1st February 2013, 1 3
6. Final approved General Chapter 〈233〉 Elemental Impurities-Limits, USP35/NF30, 2nd supplement, revision bulletin, 1st February 2013, 1 3
7. A. Liba and E. McCurdy, Proposed new USP general chapters 〈232〉 and 〈233〉 for elemental impurities: The application of ICP-MS for pharmaceutical analysis, Agilent White Paper, Agilent Publication Nr.: 5990-9382EN, Agilent, 2011
8. S. Hussain, A. Liba and E. McCurdy, Validating the ICP-MS for the analysis of elemental impurities according to draft USP General Chapters 〈232〉 and 〈233〉, Application of ICP and ICP-MS Techniques for Today's Spectroscopists, November 2011, pp. 14-19
9. S. J. Mangum K. R. Neubauer At. Spectrosc. 2010 31 159 162
10. S. J. Mangum and K. R. Neubauer, Metal impurities in pharmaceuticals and dietary supplements-Implementing ICP-MS for USP 〈232〉 and proposition 65-Application note, Perkin Elmer, 2011
11. J. Grindstaff C. Schroeder Drug Dev. Delivery 2011 11 67 70
12. A. Taylor M. P. Day J. Marshall M. Patriarca M. White J. Anal. At. Spectrom. 2012 27 537 576
13. N. Lewen S. Mathew M. Schenkenberger T. Raglione J. Pharm. Biomed. Anal. 2004 35 739 752
14. M. Schenkenberger N. Lewen Pharmacopeial Forum 2004 30 2271
15. Edelmetall-taschenbuch, ed., A. G. Degussa, Hüthig Verlag, Heidelberg, Frankfurt, Germany, 2nd edn, 1995, p. 256
16. R. D. Sauerbrunn E. B. Sandell Anal. Chim. Acta 1953 9 86 90
17. R. D. Sauerbrunn E. B. Sandell J. Am. Chem. Soc. 1953 75 3554 3556
18. V. N. Losev M. P. Bakhtina I. P. Bakhvalova A. K. Trofimchuk V. K. Runov J. Anal. Chem. 2001 56 341 347
19. K. Van Hoecke C. Catry F. Vanhaecke J. Anal. At. Spectrom. 2012 27 1909 1919